AMANDA YATABE: Open Payments
NPI 1316537756 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 19 payments from 7 companies in 2025. Trend: 2023 $425 · 2024 $713 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| ABBVIE INC. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: VRAYLAR, COBENFY, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, UZEDY, HETLIOZ, ERZOFRI EXTENDED-RELEASE.
Industry payments across FL — which companies pay providers there.
